For the final program including the abstracts please scroll down or click here.



Invited Speakers / Faculty

Björn Clausen, Erasmus University, Rotterdam, The Netherlands

Skin dendritic cell subsets: Functional specialization and molecular control in vivo

Matthew Collin, Newcastle University, Newcastle upon Tyne, UK

Human dendritic cell deficiency

Reinhold Förster, Medizinische Hochschule, Hannover, Germany

Homing of lymph derived cells to lymph node

Teunis Geijtenbeek, Academic Medical Center, University of Amsterdam, The Netherlands

C-type lectin Langerin in immunity & infections

Florent Ginhoux, Singapore Immunology Network (SIgN), Singapore

The embryonic origin of Langerhans cells: a tale of two sites

Fréderic Geissmann, King's College, London, UK

Two separate myeloid systems: origin of Langerhans cells and tissue macrophages

Dmitry Gabrilovich, Moffit Cancer Center, Tampa, FL

Mechanism of dendritic cell dysfunction in cancer

Sandrine Henri, CIML, Université de la Méditerranée, Marseille, France

Dermal dendritic cells: from phenotype to function, XCR1 as a universal marker of cross-presenting dendritic cells

Juliana Idoyaga, Rockefeller University, New York

Targeting steady state dendritic cells using anti-Langerin mAbs coupled with a self-antigen promote de novo generation of Foxp3+ regulatory T cells

Dan Kaplan, University of Minnesota, Minneapolis, MN

Control of adaptive responses by skin-resident DC subsets

Eynav Klechevsky, Washington University, St.Louis, Missouri, USA

Human Langerhans Cells: mechanism andimplications in vaccine science

Keisuke Nagao, Keio University, Tokyo, Japan

Antigen capture through tight junctions by Langerhans cells induce pre-emptive immunity in experimental staphylococcal scalded skin syndrome

Shalin Naik, Netherlands Cancer Institute, Amsterdam, The Netherlands

Dendritic cell progenitor output at the single cell level, in vivo

Frank Nestle, St. John's Institute of Dermatology, King's College, London, UK

Harnessing dendritic cells in inflammatory skin diseases

SangKon Oh, Baylor Institute for Immunology Research, Dallas, TX, USA

Harnessing human vaginal dendritic cell subsets for developing vaccines

Ethan Shevach, NIAID, NIH, Bethesda, MD

A Dendritic Cell Centric View of T Regulatory Function

Michael Sixt, Institute of Science and Technology (IST), Vienna, Austria 

Chemotactic guidance of dendritic cells in the skin

Herbert Strobl, Medical University of Vienna, Vienna, Austria

Transcription factor control of Langerhans cell differentiation

 Patrizia Stoitzner, Innsbruck Medical University, Innsbruck, Austria

Langerhans cells in tumor immunity

Marcel Teunissen, Academic Medical Center, University of Amsterdam, The Netherlands

Langerhans cells support tolerance to the bacterial skin flora

James W. Young, Memorial Sloan Kettering Cancer Center, New York

Human Langerhans-cells:  An opportunity to break tolerance against self-differentiation tumor antigens

 

Final Program LC2011